TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD))
Clinical trial NCT06169722 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06169722
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-06
- Primary completion
- 2026-02-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.